A detailed history of North Run Capital, LP transactions in Lensar, Inc. stock. As of the latest transaction made, North Run Capital, LP holds 1,096,406 shares of LNSR stock, worth $9.59 Million. This represents 7.54% of its overall portfolio holdings.

Number of Shares
1,096,406
Previous 934,510 17.32%
Holding current value
$9.59 Million
Previous $5.19 Million 37.44%
% of portfolio
7.54%
Previous 10.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.7 - $5.9 $437,119 - $955,186
161,896 Added 17.32%
1,096,406 $3.25 Million
Q3 2022

Nov 14, 2022

BUY
$4.94 - $7.0 $4.62 Million - $6.54 Million
934,510 New
934,510 $5.19 Million

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $96.4M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track North Run Capital, LP Portfolio

Follow North Run Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Run Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on North Run Capital, LP with notifications on news.